High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques

American Journal of Pathology

Volumn 184, Issue 7, 2014, Pages 2123-2133

  Vijayan, Santosh ^a,b   Asare, Yaw ^a   Grommes, Jochen ^a   Soehnlein, Oliver ^a,c   Lutgens, Esther ^c,d   Shagdarsuren, Gansuvd ^e   Togtokh, Ariunaa ^e   Jacobs, Michael J ^a,f   Fischer, Jens W ^b   Bernhagen, Jürgen ^a,c   Weber, Christian ^c,d   Schober, Andreas ^a,c   Shagdarsuren, Erdenechimeg ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT RECEPTOR; INTERLEUKIN 1BETA; PROTEIN C5L2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; C5AR1 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; CYTOKINE; GPR77 PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MACROPHAGE; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CAROTID ARTERY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; CAROTID ARTERIES; CYTOKINES; HUMANS; INTERLEUKIN-1BETA; LIPOPROTEINS, LDL; MACROPHAGES; MICE, INBRED C57BL; MICE, KNOCKOUT; PLAQUE, ATHEROSCLEROTIC; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, CHEMOKINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903156486     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.04.004     Document Type: Article

References (39)

1. R.R. Packard, A.H. Lichtman, and P. Libby Innate and adaptive immunity in atherosclerosis Semin Immunopathol 31 2009 5 22
2. C.J. Binder, M.K. Chang, P.X. Shaw, Y.I. Miller, K. Hartvigsen, A. Dewan, and J.L. Witztum Innate and acquired immunity in atherogenesis Nat Med 8 2002 1218 1226
3. C. Gerard, and N.P. Gerard C5A anaphylatoxin and its seven transmembrane-segment receptor Annu Rev Immunol 12 1994 775 808
4. I.J. Laudes, J.C. Chu, M. Huber-Lang, R.F. Guo, N.C. Riedemann, J.V. Sarma, F. Mahdi, H.S. Murphy, C. Speyer, K.T. Lu, J.D. Lambris, F.S. Zetoune, and P.A. Ward Expression and function of C5a receptor in mouse microvascular endothelial cells J Immunol 169 2002 5962 5970
5. E. Shagdarsuren, K. Bidzhekov, S.F. Mause, S. Simsekyilmaz, T. Polakowski, H. Hawlisch, J.E. Gessner, A. Zernecke, and C. Weber C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice Circulation 122 2010 1026 1036
6. P.N. Monk, A.M. Scola, P. Madala, and D.P. Fairlie Function, structure and therapeutic potential of complement C5a receptors Br J Pharmacol 152 2007 429 448
7. P. Boor, A. Konieczny, L. Villa, A.L. Schult, E. Bucher, S. Rong, U. Kunter, C.R. van Roeyen, T. Polakowski, H. Hawlisch, S. Hillebrandt, F. Lammert, F. Eitner, J. Floege, and T. Ostendorf Complement C5 mediates experimental tubulointerstitial fibrosis J Am Soc Nephrol 18 2007 1508 1515
8. J. Godau, T. Heller, H. Hawlisch, M. Trappe, E. Howells, J. Best, J. Zwirner, J.S. Verbeek, P.M. Hogarth, C. Gerard, N. Van Rooijen, A. Klos, J.E. Gessner, and J. Kohl C5a initiates the inflammatory cascade in immune complex peritonitis J Immunol 173 2004 3437 3445
9. N.J. Chen, C. Mirtsos, D. Suh, Y.C. Lu, W.J. Lin, C. McKerlie, T. Lee, H. Baribault, H. Tian, and W.C. Yeh C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a Nature 446 2007 203 207
10. A.M. Scola, K.O. Johswich, B.P. Morgan, A. Klos, and P.N. Monk The human complement fragment receptor, C5L2, is a recycling decoy receptor Mol Immunol 46 2009 1149 1162
11. N.P. Gerard, B. Lu, P. Liu, S. Craig, Y. Fujiwara, S. Okinaga, and C. Gerard An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2 J Biol Chem 280 2005 39677 39680
12. H. Gao, T.A. Neff, R.F. Guo, C.L. Speyer, J.V. Sarma, S. Tomlins, Y. Man, N.C. Riedemann, L.M. Hoesel, E. Younkin, F.S. Zetoune, and P.A. Ward Evidence for a functional role of the second C5a receptor C5L2 FASEB J 19 2005 1003 1005
13. C.E. Bamberg, C.R. Mackay, H. Lee, D. Zahra, J. Jackson, Y.S. Lim, P.L. Whitfeld, S. Craig, E. Corsini, B. Lu, C. Gerard, and N.P. Gerard The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction J Biol Chem 285 2010 7633 7644
14. D. Rittirsch, M.A. Flierl, B.A. Nadeau, D.E. Day, M. Huber-Lang, C.R. Mackay, F.S. Zetoune, N.P. Gerard, K. Cianflone, J. Kohl, C. Gerard, J.V. Sarma, and P.A. Ward Functional roles for C5a receptors in sepsis Nat Med 14 2008 551 557
15. H.D. Manthey, A.C. Thomas, I.A. Shiels, A. Zernecke, T.M. Woodruff, B. Rolfe, and S.M. Taylor Complement C5a inhibition reduces atherosclerosis in ApoE-/- mice FASEB J 25 2011 2447 2455
16. T.M. Woodruff, K.J. Costantini, J.W. Crane, J.D. Atkin, P.N. Monk, S.M. Taylor, and P.G. Noakes The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis J Immunol 181 2008 8727 8734
17. H.C. Stary, A.B. Chandler, S. Glagov, J.R. Guyton, W. Insull Jr., M.E. Rosenfeld, S.A. Schaffer, C.J. Schwartz, W.D. Wagner, and R.W. Wissler A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Arterioscler Thromb Vasc Biol 14 1994 840 856
18. H.C. Stary, A.B. Chandler, R.E. Dinsmore, V. Fuster, S. Glagov, W. Insull Jr., M.E. Rosenfeld, C.J. Schwartz, W.D. Wagner, and R.W. Wissler A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association Arterioscler Thromb Vasc Biol 15 1995 1512 1531
19. Y. Asare, E. Shagdarsuren, J.A. Schmid, P.V. Tilstam, J. Grommes, O. El Bounkari, A.K. Schutz, C. Weber, M.P. de Winther, H. Noels, and J. Bernhagen Endothelial CSN5 impairs NF-kappaB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions Thromb Haemost 110 2013 141 152
20. T. Fujiu, M. Kato, H. Kimura, A. Tachibana, M. Suzuki, Y. Nako, and A. Morikawa Cellular adhesion is required for effector functions of human eosinophils via G-protein coupled receptors Ann Allergy Asthma Immunol 89 2002 90 98
21. W.S. Speidl, S.P. Kastl, R. Hutter, K.M. Katsaros, C. Kaun, G. Bauriedel, G. Maurer, K. Huber, J.J. Badimon, and J. Wojta The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro FASEB J 25 2011 35 44
22. W.S. Speidl, K.M. Katsaros, S.P. Kastl, G. Zorn, K. Huber, G. Maurer, J. Wojta, and G. Christ Coronary late lumen loss of drug eluting stents is associated with increased serum levels of the complement components C3a and C5a Atherosclerosis 208 2010 285 289
23. R. Oksjoki, P. Laine, S. Helske, P. Vehmaan-Kreula, M.I. Mayranpaa, P. Gasque, P.T. Kovanen, and M.O. Pentikainen Receptors for the anaphylatoxins C3a and C5a are expressed in human atherosclerotic coronary plaques Atherosclerosis 195 2007 90 99
24. M. Otto, H. Hawlisch, P.N. Monk, M. Muller, A. Klos, C.L. Karp, and J. Kohl C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism J Biol Chem 279 2004 142 151
25. C. Roy, A. Gupta, A. Fisette, M. Lapointe, P. Poursharifi, D. Richard, H. Lu, B. Lu, N. Gerard, C. Gerard, and K. Cianflone C5a receptor deficiency alters energy utilization and fat storage PLoS One 8 2013 e62531
26. J. Yuan, S.J. Gou, J. Huang, J. Hao, M. Chen, and M.H. Zhao C5a and its receptors in human anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis Arthritis Res Ther 14 2012 R140
27. K. Tokodai, M. Goto, A. Inagaki, T. Imura, W. Nakanishi, and S. Satomi Expression of receptors for anaphylatoxins C3a and C5a on rat islet preparations Transplant Proc 43 2011 3179 3180
28. H. Ohta, H. Wada, T. Niwa, H. Kirii, N. Iwamoto, H. Fujii, K. Saito, K. Sekikawa, and M. Seishima Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice Atherosclerosis 180 2005 11 17
29. C.A. Dinarello A clinical perspective of IL-1beta as the gatekeeper of inflammation Eur J Immunol 41 2011 1203 1217
30. M.R. Alexander, C.W. Moehle, J.L. Johnson, Z. Yang, J.K. Lee, C.L. Jackson, and G.K. Owens Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice J Clin Invest 122 2012 70 79
31. P.M. Ridker, T. Thuren, A. Zalewski, and P. Libby Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) Am Heart J 162 2011 597 605
32. J. Hao, C. Wang, J. Yuan, M. Chen, and M.H. Zhao A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation PLoS One 8 2013 e66305
33. P. Poursharifi, M. Lapointe, D. Petrin, D. Devost, D. Gauvreau, T.E. Hebert, and K. Cianflone C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology Cell Signal 25 2012 910 918
34. H. Itabe Oxidized low-density lipoproteins: what is understood and what remains to be clarified Biol Pharm Bull 26 2003 1 9
35. V.V. Kunjathoor, M. Febbraio, E.A. Podrez, K.J. Moore, L. Andersson, S. Koehn, J.S. Rhee, R. Silverstein, H.F. Hoff, and M.W. Freeman Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages J Biol Chem 277 2002 49982 49988
36. S. Paglialunga, P. Schrauwen, C. Roy, E. Moonen-Kornips, H. Lu, M.K. Hesselink, Y. Deshaies, D. Richard, and K. Cianflone Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice J Endocrinol 194 2007 293 304
37. R. Li, L.G. Coulthard, M.C. Wu, S.M. Taylor, and T.M. Woodruff C5L2: A controversial receptor of complement anaphylatoxin, C5a FASEB J 27 2012 855 864
38. M. Huber-Lang, J.V. Sarma, D. Rittirsch, H. Schreiber, M. Weiss, M. Flierl, E. Younkin, M. Schneider, H. Suger-Wiedeck, F. Gebhard, S.D. McClintock, T. Neff, F. Zetoune, U. Bruckner, R.F. Guo, P.N. Monk, and P.A. Ward Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans J Immunol 174 2005 1104 1110
39. C. Weber, and H. Noels Atherosclerosis: current pathogenesis and therapeutic options Nat Med 17 2011 1410 1422